Slyde Analytics v. Zepp Health: 7-Patent Smartwatch Dispute Ends in Dismissal With Prejudice
Slyde Analytics, LLC asserted seven US patents covering wearable fitness-tracking and gesture-interaction technology against Zepp Health Corporation’s broad Amazfit and Zepp product lines. Filed in the Eastern District of Texas in April 2023, the case resolved after 689 days with a joint dismissal with prejudice — each party bearing its own costs — suggesting a negotiated resolution rather than a litigated verdict.
Seven-Patent Smartwatch Assault on Zepp Health Ends in Negotiated Exit
Slyde Analytics, LLC — a patent-holding entity — filed suit against Zepp Health Corporation in the Eastern District of Texas on 14 April 2023, asserting seven US patents: US9651922B2, US8588033B2, US9320457B2, US10198085B2, US9804678B2, US9873018B2, and US9536134B2. The patents relate to wearable device technology encompassing fitness tracking, gesture interaction, and user-interface control, and were asserted against 39 distinct Amazfit and Zepp-branded smartwatch and fitness-band products.
The case closed on 3 March 2025 via a joint motion to dismiss filed by both parties. The court granted the motion and dismissed all claims with prejudice, meaning Slyde Analytics cannot refile the same claims against Zepp Health in future proceedings. Notably, the order directed each party to bear its own costs, expenses, and attorneys’ fees — a cost-neutrality provision consistent with a confidential settlement agreement in which financial or licensing terms are not reflected in the public record.
The 689-day duration suggests the case progressed meaningfully — likely through claim construction or early discovery — before the parties reached commercial resolution. The breadth of the patent portfolio (seven patents) and product scope (39 SKUs) typically signals plaintiff leverage at the outset; dismissal with prejudice and mutual cost-bearing, rather than a contested judgment, suggests Zepp Health may have secured a license or other commercial arrangement. What precisely was exchanged remains unknown from publicly available filings.
Filing to Dismissed with Prejudice in 689 days
689-day duration — roughly 23 months from filing to close in E.D. Tex.
Dismissed with prejudice: what the joint exit means for both parties
Dismissal with prejudice closes the door permanently
A dismissal with prejudice under Fed. R. Civ. P. 41(a)(2) is a final adjudication on the merits for res judicata purposes. Slyde Analytics cannot refile these seven patent claims against Zepp Health in any federal court. The joint nature of the motion — agreed by both parties — is the hallmark of a negotiated resolution rather than a court-imposed outcome.
Permanent bar on refilingSlyde’s claims extinguished — but likely monetised first
By agreeing to dismissal with prejudice, Slyde Analytics surrenders the right to pursue these specific claims against Zepp Health indefinitely. However, plaintiffs in NPE-style litigation rarely accept permanent dismissal without extracting value. The cost-neutrality order (each party bears own fees) is strongly consistent with an undisclosed licence or lump-sum payment having been reached before the joint motion was filed.
Likely licensed exitZepp Health secures finality across 39 product SKUs
Zepp Health obtains a clean exit from litigation covering its entire Amazfit and Zepp smartwatch range. The with-prejudice bar eliminates residual litigation risk from Slyde on these seven patents. Whether Zepp secured a royalty-free licence or paid for the dismissal is not disclosed, but the breadth of product coverage — 39 SKUs — gives Zepp meaningful commercial certainty going forward.
Full product-line finalityWearable IP remains high-stakes; Slyde’s portfolio still active
The seven asserted patents survive this case intact and remain enforceable against other wearable device makers. Competitors selling gesture-control or fitness-tracking smartwatches — particularly those not yet holding a licence from Slyde — should treat this resolution as a signal that the portfolio is being actively monetised. The E.D. Tex. venue choice further underscores an aggressive enforcement posture.
Portfolio still in playFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Slyde Analytics, LLC | Company | Patent-holding entity — asserting 7 US wearable fitness-tracking patentsSearch in Eureka ↗ |
| Defendant | Zepp Health Corporation | Company | Zepp Health Corporation — maker of Amazfit and Zepp smartwatch product linesSearch in Eureka ↗ |
| Plaintiff counsel | Jacob Daniel Ostling | Attorney | Counsel for Slyde Analytics, LLCSearch in Eureka ↗ |
| Plaintiff counsel | John Andrew Rubino | Attorney | Counsel for Slyde Analytics, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Justin Kurt Truelove | Attorney | Counsel for Slyde Analytics, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Justine Minseon Park | Attorney | Counsel for Slyde Analytics, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Michael Mondelli , III | Attorney | Counsel for Slyde Analytics, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Vincent J. Rubino , III | Attorney | Counsel for Slyde Analytics, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Fabricant LLP (NY) | Law Firm | Representing Slyde Analytics, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Fabricant LLP (Rye) | Law Firm | Representing Slyde Analytics, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Rubino Ip | Law Firm | Representing Slyde Analytics, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Rubino Law LLC | Law Firm | Representing Slyde Analytics, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Truelove Law Firm | Law Firm | Representing Slyde Analytics, LLCSearch in Eureka ↗ |
| Defendant counsel | Donald R. McPhail | Attorney | Counsel for Zepp Health CorporationSearch in Eureka ↗ |
| Defendant counsel | Eric W. Schweibenz | Attorney | Counsel for Zepp Health CorporationSearch in Eureka ↗ |
| Defendant counsel | Paige S. Stradley | Attorney | Counsel for Zepp Health CorporationSearch in Eureka ↗ |
| Defendant law firm | Merchant & Gould PC | Law Firm | Representing Zepp Health CorporationSearch in Eureka ↗ |
| Defendant law firm | Merchant & Gould PC (Minneapolis) | Law Firm | Representing Zepp Health CorporationSearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The court’s order reflects a purely consensual exit: both parties jointly requested dismissal, and the court granted it without reaching any merits question. The with-prejudice designation carries full res judicata effect — these seven patent claims cannot be reasserted against Zepp Health by Slyde Analytics. The mutual cost-bearing provision is notable because it departs from the default American rule only by confirming neither party sought fee-shifting, which is consistent with a negotiated financial resolution outside the court record. No finding of validity, invalidity, infringement, or non-infringement was made.
US9651922B2 — Wearable device fitness tracking and gesture interaction patents
The seven patents-in-suit — US9651922B2, US8588033B2, US9320457B2, US10198085B2, US9804678B2, US9873018B2, and US9536134B2 — span application filings from 2011 through 2017, reflecting an IP portfolio assembled across successive generations of consumer wearable technology. The patents collectively cover core wearable device functions including biometric sensing, fitness-metric computation, gesture-based user input, and power-efficient data management on wrist-worn devices — capabilities that underpin virtually every modern smartwatch and fitness band.
Strategically, a portfolio this broad — seven issued patents covering both hardware-level sensing and software-level interaction — gives the holder significant leverage over wearable OEMs. Zepp Health’s Amazfit line competes directly in a market segment where these patented functions are table-stakes features. Any wearable manufacturer shipping heart-rate monitoring, step counting, gesture navigation, or sleep-tracking capabilities without a licence to this portfolio carries residual infringement exposure. The resolution here does not invalidate any claim — meaning the portfolio remains a live threat to unlicensed competitors.
Should you run an FTO against Slyde Analytics’ wearable patent portfolio?
Any company designing, manufacturing, or importing smartwatches, fitness bands, or health-monitoring wearables into the US market should treat this case as a direct prompt for FTO review. The seven Slyde Analytics patents survived litigation intact — no IPR filings, no invalidity findings, no claim amendments appear in the public record. If your product includes gesture control, biometric tracking, or activity-data processing, at least one of these patents is likely worth mapping against your device architecture before US market entry or next product generation launch.
PatSnap Eureka’s FTO Search Agent can map each of the seven Slyde Analytics patents against your product’s claim set, flag independent claims that pose the highest infringement risk, and surface prior art that may support future IPR petitions. Eureka’s litigation monitoring layer also tracks whether Slyde Analytics has filed additional complaints against other wearable brands — giving your IP team early warning before you receive a demand letter rather than after.
Run a freedom-to-operate analysis on US9651922B2 to assess your product’s exposure
Run FTO in Eureka →Similar wearable technology patent cases in E.D. Tex. and related courts
Cases involving wearable fitness-tracking and gesture-interaction patents litigated in the Eastern District of Texas against consumer electronics makers.
What this case signals for the wearable technology IP landscape
A 7-patent assertion against 39 smartwatch SKUs in E.D. Tex. is a deliberate enforcement strategy — and the outcome offers clear lessons.
Breadth of assertion amplifies settlement pressure in wearable IP disputes
Asserting seven patents across 39 product SKUs in a plaintiff-friendly venue creates compounding discovery and invalidity-defence costs for the defendant. Zepp Health’s joint exit after 689 days — without a contested verdict — is consistent with a calculus where settlement cost fell below total defence cost. Wearable device makers should model this risk before launch.
Each-party-bears-own-costs is a reliable settlement signal in NPE cases
When neither party recovers fees, it typically means a private payment was agreed outside court. Fee-shifting under 35 U.S.C. § 285 requires an ‘exceptional case’ finding — something the parties avoided by settling. R&D and legal teams tracking NPE activity should use cost-neutrality orders as a proxy for undisclosed licence agreements in public dockets.
Slyde v Zepp — key questions answered
Slyde Analytics filed a patent infringement suit against Zepp Health in the Eastern District of Texas on 14 April 2023, asserting seven US patents against 39 Amazfit and Zepp smartwatch products. The case closed on 3 March 2025 — 689 days later — when the court granted a joint motion to dismiss all claims with prejudice. Each party was ordered to bear its own costs.
Slyde Analytics asserted seven US patents: US9651922B2, US8588033B2, US9320457B2, US10198085B2, US9804678B2, US9873018B2, and US9536134B2. These patents cover wearable device technology including fitness tracking, biometric sensing, gesture-based user interaction, and activity data processing — all standard features of the Amazfit smartwatch line.
Dismissal with prejudice is a final disposition that operates as res judicata. Slyde Analytics is permanently barred from asserting the same seven patents against Zepp Health in any future federal court proceeding. However, those patents remain enforceable against other defendants — the dismissal only releases Zepp Health, not the broader market.
The public record does not confirm a settlement explicitly. However, the joint motion to dismiss and the cost-neutrality order — each party bearing its own fees — are strongly consistent with a negotiated resolution, potentially including a licence or lump-sum payment. The terms of any such agreement are not disclosed in court filings.
Yes. The dismissal with prejudice releases only Zepp Health from liability under these seven patents. No claim was found invalid, and no IPR petition appears in the public record. All seven patents remain issued, in-force, and enforceable against any other party manufacturing or selling wearable devices that may read on the asserted claims.
PatSnap Eureka searches patents and litigation data to answer instantly.